435 related articles for article (PubMed ID: 17708366)
21. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
[TBL] [Abstract][Full Text] [Related]
22. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
23. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival of patients with carcinoid tumor and liver metastases.
Stathopoulos GP; Papadopoulos G; Koutantos J
J BUON; 2009; 14(4):609-11. PubMed ID: 20148450
[TBL] [Abstract][Full Text] [Related]
25. Peritoneal carcinomatosis in patients with digestive endocrine tumors.
Vasseur B; Cadiot G; Zins M; Fléjou JF; Belghiti J; Marmuse JP; Vilgrain V; Bernades P; Mignon M; Ruszniewski P
Cancer; 1996 Oct; 78(8):1686-92. PubMed ID: 8859181
[TBL] [Abstract][Full Text] [Related]
26. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
[TBL] [Abstract][Full Text] [Related]
27. Bronchial carcinoid tumors: long-term outcome after surgery.
Fiala P; Petrásková K; Cernohorský S; Kinkor Z; Krepela E; Zatloukal P
Neoplasma; 2003; 50(1):60-5. PubMed ID: 12687280
[TBL] [Abstract][Full Text] [Related]
28. Developments in diagnosis and treatment of metastatic midgut carcinoid tumors. A review.
Taal BG; Smits M
Minerva Gastroenterol Dietol; 2005 Dec; 51(4):335-44. PubMed ID: 16282961
[TBL] [Abstract][Full Text] [Related]
29. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
30. Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases.
Soga J
J Exp Clin Cancer Res; 2003 Mar; 22(1):5-15. PubMed ID: 12725316
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular abnormalities in patients with a carcinoid syndrome.
Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
[TBL] [Abstract][Full Text] [Related]
32. Primary endocrine tumours of the liver.
Maire F; Couvelard A; Vullierme MP; Kianmanesh R; O'Toole D; Hammel P; Belghiti J; Ruszniewski P
Br J Surg; 2005 Oct; 92(10):1255-60. PubMed ID: 15988793
[TBL] [Abstract][Full Text] [Related]
33. Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.
Korse CM; Bonfrer JM; Aaronson NK; Hart AA; Taal BG
Neuroendocrinology; 2009; 89(3):296-301. PubMed ID: 18840995
[TBL] [Abstract][Full Text] [Related]
34. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
35. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of laparoscopic and open resection for neuroendocrine liver metastases.
Kandil E; Noureldine SI; Koffron A; Yao L; Saggi B; Buell JF
Surgery; 2012 Dec; 152(6):1225-31. PubMed ID: 23068086
[TBL] [Abstract][Full Text] [Related]
37. [Surgical treatment of endocrine-cell tumors of hepato-pancreatic-duodenal zone (comment of the editor)].
Patiutko IuI; Badalian KhV
Khirurgiia (Mosk); 2002; (4):17-21. PubMed ID: 12001676
[TBL] [Abstract][Full Text] [Related]
38. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
[TBL] [Abstract][Full Text] [Related]
39. Carcinoid tumours of the testis.
Stroosma OB; Delaere KP
BJU Int; 2008 May; 101(9):1101-5. PubMed ID: 18190641
[TBL] [Abstract][Full Text] [Related]
40. Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients.
Rea F; Rizzardi G; Zuin A; Marulli G; Nicotra S; Bulf R; Schiavon M; Sartori F
Eur J Cardiothorac Surg; 2007 Feb; 31(2):186-91. PubMed ID: 17140801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
